SEC Form 4 · accession 0001144204-16-080228
Accelerate Diagnostics, Inc · AXDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Matthew Strobeck
Director
Period of report
Feb 9, 2016
Accepted (ET)
Feb 10, 2016 · 11:48 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000727207
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 9, 2016 | P | 20,000 | $11.52 | A | 130,235 | I | Through Birchview Fund, LLC |
| Common Stock | holding | — | — | — | 2,045,560 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person has sole voting and dispositive power with respect to the shares held by Birchview Fund, LLC in his capacity as the CEO of such entity. The reporting person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.